NPSR1-AS1 and metabolic dysfunction-associated steatotic liver disease: Autoantibodies against apolipoprotein A-1 (AAA-1) are a possible novel CVD risk factor promoting inflammation and disrupting cellular lipid homeostasis, two prominent pathogenic features of NAFLD.